Leukemia Research Foundation

06/12/2026

Dr. Caner Saygin, a hematologist/oncologist at The University of Chicago and a recipient of a 2025 Leukemia Research Foundation New Investigator Research Grant, talks with Dionne Miller ABC7 at the 32nd Annual ABC7 Gibbons 5KRun, about how ongoing leukemia research is creating new therapies and new hopes for patients. Check out the video! https://youtu.be/QVGZp5pyqyo

Proceeds from the event benefit the Leukemia Research Foundation, the nation’s largest nonprofit focused exclusively on funding leukemia research and supporting leukemia patients and their loved ones.

Dr. Caner Saygin, a hematologist/oncologist at the University of Ch...

06/12/2026

Kevin Radelet, executive director of the Leukemia Research Foundation, and Jaime Moran, Foundation Board member and healthcare executive, talk with Dionne Miller ABC7 about the Foundation’s defined strategy, impact, and the importance of funding early career researchers, during the 32nd Annual ABC7 Gibbons Run in Chicago. Check out the video: https://youtu.be/n_DhC9sXbRE

Kevin Radelet, executive director of the Leukemia Research Foundati...

06/10/2026

Nancy Zurawski, who was diagnosed with chronic lymphocytic leukemia (CLL) in 2007, and her son Matt, share their story with Dionne Miller ABC7. Nancy has participated in the ABC7 Gibbons Run for 19 years with a team of friends and family, and believes this is "just such a great day of hope." Thanks for sharing your story, Nancy!

Check out this video: https://youtu.be/3P5jnWfgOZc

06/10/2026

Suzanne and her son Landon, an ALL patient and a recent high school graduate, shared their story with Miller ABC7 at the 32nd Annual ABC7 Gibbons 5K Run in Chicago, highlighting the importance of having support during these times. This includes the support of friends, family and his whole high school basketball team, who joined them at the Run! Thank you to all!!

Check out the video: https://youtu.be/7550bjx41Mg

06/03/2026

Amy Harris, a chronic lymphocytic leukemia (CLL) patient, was one of the many virtual runners who took part in Saturday's 32nd Annual ABC7 Gibbons 5K Run and 3K Walk. Amy, a member of the Patient Advisory Committee, did her run in Nashville, Tennessee, helping to raise funds for leukemia research! Thank you, Amy!!
https://bit.ly/3PPMQIZ

, ,

05/27/2026

Buddy the Blood Drop and runners and walkers from all over the Chicagoland area will join us this Saturday, May 30 at Montrose Harbor for the 32nd ABC7 ABC 7 Gibbons Run and Walk. Register now or register onsite, and get ready to Lace Up For Leukemia! https://bit.ly/4dPvDHG

Back again this year, Buddy the Blood Drop.
Find him. Snap a pic.

05/27/2026

This month marks 25 years since a revolutionary drug, Gleevec, was approved by the FDA, transforming chronic myeloid leukemia (CML) from a fatal diagnosis to a highly manageable condition.

Contributing to this drug’s discovery was the work of renowned University of Chicago researcher Dr. Janet Rowley. Dr. Rowley had received two grants from the Leukemia Research Foundation to fund her CML research. She discovered a recurring chromosome translocation – an abnormality when a chromosome breaks and a fragmented piece reattaches to another chromosome - which resulted in the Philadelphia chromosome seen in CML.

This historic finding helped spur the development and ultimate discovery of Gleevec, which changed the CML survival rate from 3-to-5 years into a normal life expectancy. Learn more about our research grant program: https://bit.ly/4tSRTX3

05/22/2026

This month marks 25 years since a revolutionary drug, Gleevec, was approved by the FDA, transforming chronic myeloid leukemia (CML) from a fatal diagnosis to a highly manageable condition.

Contributing to this drug’s discovery was the work of renowned University of Chicago researcher Dr. Janet Rowley. Dr. Rowley had received two grants from the Leukemia Research Foundation to fund her CML research. She discovered a recurring chromosome translocation – an abnormality when a chromosome breaks and a fragmented piece reattaches to another chromosome - which resulted in the Philadelphia chromosome seen in CML.

This historic finding helped spur the development and ultimate discovery of Gleevec, which changed the CML survival rate from 3-to-5 years into a normal life expectancy. Learn more about our research grant program: https://bit.ly/4tSRTX3

05/21/2026

In a study published in the journal Science Translational Medicine, a team of scientists from The Jackson Laboratory revealed not only a potential new way to treat acute myeloid leukemia (AML) without harsh chemotherapy, but also a promising strategy to study more gene-silencing mechanisms in other diseases.

The research, led by Eric Wang, PhD, a 2024 Leukemia Research Foundation New Investigator Research Grant (NIRG) recipient, was funded in part by the Foundation. In addition, two former NIRG recipients also contributed to this study: Hussein Abbas, MD, PhD (2022) and Iannis Aifantis, PhD (2003).

Learn more about the study: https://bit.ly/4eV4ncS

05/06/2026

Happy National Nurses Week! Nurses play a key part in any treatment plan. This short video clip from our recent webinar, "Your Care Team", features Dawn Urbanovsky, RN, BSN, OCN, a treatment nurse navigator from MD Anderson, who discusses the role of treatment nurse navigators and how they can help patients set up second opinions, as she does at MD Anderson. Watch video clip: https://bit.ly/4tJyOY5